Biolife Solutions (BLFS) Invested Capital (2016 - 2025)
Historic Invested Capital for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $361.2 million.
- Biolife Solutions' Invested Capital rose 454.86% to $361.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $361.2 million, marking a year-over-year increase of 454.86%. This contributed to the annual value of $364.8 million for FY2024, which is 92.39% up from last year.
- Per Biolife Solutions' latest filing, its Invested Capital stood at $361.2 million for Q3 2025, which was up 454.86% from $357.2 million recorded in Q2 2025.
- In the past 5 years, Biolife Solutions' Invested Capital registered a high of $497.2 million during Q3 2021, and its lowest value of $209.2 million during Q1 2021.
- Over the past 5 years, Biolife Solutions' median Invested Capital value was $365.6 million (recorded in 2025), while the average stood at $386.7 million.
- Per our database at Business Quant, Biolife Solutions' Invested Capital soared by 33089.71% in 2021 and then plummeted by 2068.48% in 2023.
- Biolife Solutions' Invested Capital (Quarter) stood at $485.3 million in 2021, then fell by 19.67% to $389.8 million in 2022, then decreased by 7.26% to $361.5 million in 2023, then rose by 0.92% to $364.8 million in 2024, then dropped by 0.99% to $361.2 million in 2025.
- Its Invested Capital stands at $361.2 million for Q3 2025, versus $357.2 million for Q2 2025 and $365.6 million for Q1 2025.